Table 1.
Clinical trial identifier | Disease/condition | Trial status | Sponsor | Country |
---|---|---|---|---|
NCT02741518 | Obesity | Phase 1 | Brigham and Women's Hospital | USA |
NCT02530385 | Obesity | Phase 2 | Massachusetts General Hospital | USA |
NCT03926286 | Sjogren's Syndrome | Phase 1 | University of Miami | USA |
NCT02255617 | Hepatic Encephalopathy | Phase 1 | University of Alberta | Canada |
NCT02960074 | Peanut allergy | Phase 1 | Boston Children's Hospital | USA |
NCT03594487 | Relapsing-remitting MS | Phase 1 | University of California, San Francisco | USA |
NCT03998423 | Alzheimer's disease (AD) | Phase 1 | University of Wisconsin, Madison | USA |
NCT03353402 | Metastatic Melanoma Patients Who Failed Immunotherapy | Phase 1 | Sheba Medical Center | USA |
NCT03341143 | Melanoma | Melanoma | University of Pittsburgh | USA |
NCT04014413 | a variety of dysbiosis-associated disorder | N/A | Chinese University of Hong Kong | China |
NCT04251767 | COVID-19 Complicated with Refractory Intestinal Infections | N/A | The Second Hospital of Nanjing Medical University | China |
NCT03058900 | Psoriatic Arthritis | Completed | Odense University Hospital | Denmark |
NCT03279224 | Bipolar Depression | Phase 2: Allogenic Phase 3: Autologous |
Women's College Hospital | Canada |
NCT03281044 | Major Depressive Disorder | Melanoma | Psychiatric Hospital of the University of Basel | Switzerland |
Abbreviations: USA: United States of America.